fbpx

< Back to Thought Leadership

Medicare Part B Reimbursement Cuts To 340B Hospitals

In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B Program, adjusting reimbursement amounts based on a value of Average Sales Price (ASP) – 22.5% from the previous value of ASP + 6%. This was challenged in court almost immediately by many 340B stakeholders. In December of 2019, a federal district judge ruled the CMS exceeded its statutory authority by implementing this reduction. CMS appealed, and the reductions remained in place as the case progressed.

On August 1, 2020, a divided federal appeals court ruled the cuts to 340B hospitals’ Medicare Part B drug reimbursement under the hospital outpatient prospective payment system (OPPS) “rests on a reasonable interpretation of the Medicare statute.” The 2-1 decision by the U.S. Court of Appeals for the District of Columbia Circuit overturned previous rulings and allows for reduced reimbursements established in 2018. Hospitals will certainly continue the fight and file appeals to the next level.

The ruling is a blow to 340B hospitals, many already struggling during the pandemic. Just a few days later, CMS proposed an additional 6.2% reimbursement reduction for calendar year 2021. Medicare Part B payment for DSHs, RRCs, and non-rural SCHs will be ASP – 28.7%. Comments are due on this proposal by October 5th.

Rural SCHs are not subject to the reduction in reimbursement. However, the proper modifiers must be reported on the UB billing form.

We will continue to monitor developments and provide updates as available. If you have any questions, please reach out to one of our Apexus Certified 340B Experts.

 

not-for-profit cecl model

Decoding The New CECL Model for Not-For-Profits

By Priya Singleton, CPA, Director at Blue & Co. The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of […]

Learn More

Final Hospital 340B Outpatient Prospective Payment System (“OPPS”) Remedy

On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) released a final rule outlining a plan to correct and reverse the 340B payment cuts from calendar years […]

Learn More
restricted fund tracking

Restricted Fund Tracking and Cash Management

By Andrew Brock, CPA, Senior Manager at Blue & Co. Earlier in June 2023, an article was published by our not-for-profit services team titled “Unveiling the Dynamics of Donor-Restricted Contributions”. […]

Learn More